Bronchoscopic Laser Ablation of Peripheral Lung Tumors
Not Applicable
Terminated
- Conditions
- Lung Carcinoid TumorMetastatic Lung CarcinomaLung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8Stage IVA Lung Cancer AJCC v8Stage IVB Lung Cancer AJCC v8
- Interventions
- Procedure: Cone-Beam Computed TomographyProcedure: Conventional SurgeryProcedure: Laser Ablation
- First Posted Date
- 2018-10-16
- Last Posted Date
- 2023-02-16
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 4
- Registration Number
- NCT03707925
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Local Consolidative Therapy and Brigatinib in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer
Phase 1
Active, not recruiting
- Conditions
- Stage IV Lung Cancer AJCC v8Stage IVA Lung Cancer AJCC v8Advanced Lung CarcinomaStage IVB Lung Cancer AJCC v8ALK Gene RearrangementLung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell Carcinoma
- Interventions
- Drug: BrigatinibProcedure: Local Consolidation Therapy
- First Posted Date
- 2018-10-16
- Last Posted Date
- 2024-10-21
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 35
- Registration Number
- NCT03707938
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
ADCT-602 in Treating Patients with Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia
Phase 1
Recruiting
- Conditions
- CD22 PositivePhiladelphia Chromosome PositiveRecurrent B Acute Lymphoblastic LeukemiaBlasts 5 Percent or More of Bone Marrow Nucleated CellsRefractory B Acute Lymphoblastic Leukemia
- Interventions
- Biological: ADCT-602
- First Posted Date
- 2018-10-09
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 57
- Registration Number
- NCT03698552
- Locations
- 🇺🇸
City of Hope Comprehensive Cancer, Monrovia, California, United States
🇺🇸M D Anderson Cancer Center, Houston, Texas, United States
Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive Chemoradiation for Newly Diagnosed Squamous Cell Carcinoma of the Anal Canal: a Feasibility Trial
Phase 2
Completed
- Conditions
- Anal Canal Squamous Cell CarcinomaStage I Anal Cancer AJCC v8Stage II Anal Cancer AJCC v8Stage IIA Anal Cancer AJCC v8Stage IIB Anal Cancer AJCC v8Stage III Anal Cancer AJCC v8Stage IIIA Anal Cancer AJCC v8Stage IIIC Anal Cancer AJCC v8Stage IIIB Anal Cancer AJCC v8
- Interventions
- Drug: CisplatinDrug: FluorouracilRadiation: Linear Energy Transfer-Optimized Intensity Modulated Proton TherapyProcedure: Quality-of-Life AssessmentOther: Questionnaire Administration
- First Posted Date
- 2018-10-01
- Last Posted Date
- 2023-06-29
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 8
- Registration Number
- NCT03690921
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
DECT in Imaging Patients With Solid Organ Cancer With Intracranial Metastasis
Not Applicable
Completed
- Conditions
- Metastatic Malignant Neoplasm in the BrainMalignant Neoplasm
- Interventions
- Procedure: Dual-Energy Computed Tomography
- First Posted Date
- 2018-09-26
- Last Posted Date
- 2023-08-31
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 42
- Registration Number
- NCT03685539
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation
Phase 2
Recruiting
- Conditions
- Acute Bilineal LeukemiaAcute Biphenotypic LeukemiaRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaIDH2 Gene MutationMyelodysplastic Syndrome
- Interventions
- First Posted Date
- 2018-09-25
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 50
- Registration Number
- NCT03683433
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Ultra Low-Dose Radiation Therapy in Treating Patients with Stage I-IV Stomach MALT Lymphoma
Early Phase 1
Active, not recruiting
- Conditions
- Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
- Interventions
- Drug: Radiation Therapy
- First Posted Date
- 2018-09-21
- Last Posted Date
- 2024-10-30
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 25
- Registration Number
- NCT03680586
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Electronic Neurocognitive Tools in Screening for Mental Capability in Patients Undergoing Liver Surgery
Not Applicable
Active, not recruiting
- Conditions
- Liver and Intrahepatic Bile Duct Disorder
- Interventions
- Behavioral: BrainCheck Cognitive AssessmentProcedure: Cognitive Assessment
- First Posted Date
- 2018-09-19
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 100
- Registration Number
- NCT03678441
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Patients Navigators in Facilitating Weight Management in Obese Participants
Not Applicable
Active, not recruiting
- Conditions
- ObesityHealth Status Unknown
- Interventions
- Other: Informational InterventionOther: Questionnaire AdministrationBehavioral: Telephone-Based Intervention
- First Posted Date
- 2018-09-17
- Last Posted Date
- 2024-10-10
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 171
- Registration Number
- NCT03674229
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Preference of Room Setting and Waiting Time in Patients With Advanced, Locally Advanced, or Metastatic Cancer and Their Caregivers Who Are Seen in the Outpatient Supportive/Palliative Care Center
Not Applicable
Active, not recruiting
- Conditions
- Advanced Malignant NeoplasmMetastatic Malignant NeoplasmCaregiverLocally Advanced Malignant Neoplasm
- Interventions
- Other: Questionnaire Administration
- First Posted Date
- 2018-09-14
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 406
- Registration Number
- NCT03671226
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath